Cited by 297Cardiac pacing and defibrillation studiesCardiac Arrest and ResuscitationCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Aggregate National Experience With the Wearable Cardioverter-Defibrillator

Open access

Chung, Mina K., Szymkiewicz, Steven J., Shao, Mingyuan, Zishiri, Edwin, Niebauer, Mark J., Lindsay, Bruce D., Tchou, Patrick J.·2010·Journal of the American College of Cardiology

DOI 10.1016/j.jacc.2010.04.016PMC PMC2962668

Open this paper in CoChat — free account

Abstract

Objectives The purpose of this study was to determine patient compliance and effectiveness of antiarrhythmic treatment by the wearable cardioverter-defibrillator (WCD).Background Effectiveness of the WCD for prevention of sudden death is dependent on event type, patient compliance, and appropriate management of ventricular tachycardia/ventricular fibrillation (VT/VF).Methods Compliance and events were recorded in a nationwide registry of post-market release WCDs. Survival, using the Social Security Death Index, was compared with survival in implantable cardioverter-defibrillator (ICD) patients.Results Of 3,569 patients wearing the WCD (age 59.3+/-14.7 years, duration 52.6+/-69.9 days), daily use was 19.9+/-4.7 h (>90% of the day) in 52% of patients. More days of use correlated with higher daily use (p<0.001). Eighty sustained VT/VF events occurred in 59 patients (1.7%). First-shock success was 76 of 76 (100%) for unconscious VT/VF and 79 of 80 (99%) for all VT/VF. Eight patients died after successful conversion of unconscious VT/VF (89.5% survival of VT/VF events). Asystole occurred in 23 (17 died), pulseless electrical activity in 2, and respiratory arrest in 1 (3 died), representing 24.5% of sudden cardiac arrests. During WCD use, 3,541 of 3,569 patients (99.2%) survived overall. Survival occurred in 72 of 80 (90%) VT/VF events and 78 of 106 (73.6%) for all events. Long-term mortality was not significantly different from first ICD implant patients but highest among patients with traditional ICD indications.Conclusions Compliance was satisfactory with 90% wear time in >50% of patients and low sudden death mortality during use. Survival was comparable to that of ICD patients. However, asystole was an important cause of mortality in sudden cardiac arrest events.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2010.04.016

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction
Moss, A. J., Zaręba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,885
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias
The AVID Investigators (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,221
PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION
Oss, J. M., Areba, W. O. Z., Ackson, W. J., Lein, H. E. K., Ilber, D. A. J. W., Annom, D. A. S. C., Ames, J. M., Aubert, P., Iggins, S. T. L. H., Rown, M. A. W. B., et al. (2002) · Cited by 2,026
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction
Hohnloser, S. H., Kuck, K. H., Dorian, P., Roberts, R. S., Hampton, J. R., Hatala, R., Fain, E., Gent, M., & Connolly, S. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041489 · Cited by 1,519
Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both
Solomon, S. D., Zelenkofske, S., McMurray, J. J. V., Finn, P. V., Velazquez, E. J., Ertl, G., Harsanyi, A., Rouleau, J. L., Maggioni, A. P., Køber, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043938 · Cited by 800
Impact of Medication Therapy Discontinuation on Mortality After Myocardial Infarction
Ho, P. M., Spertus, J. A., Masoudi, F. A., Reid, K. J., Peterson, E. D., Magid, D. J., Krumholz, H. M., & Rumsfeld, J. S. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.17.1842 · Cited by 635
Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both
(2005) · New England Journal of Medicine · doi:10.1056/nejm200508183530725 · Cited by 601
Dual-Chamber Versus Single-Chamber Detection Enhancements for Implantable Defibrillator Rhythm Diagnosis
Friedman, P. A., McClelland, R. L., Bamlet, W. R., Acosta, H., Kessler, D. J., Munger, T. M., Kavesh, N. G., Wood, M., Daoud, E. G., Massumi, A., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.594531 · Cited by 255

Flagged first, then by citations

Show all 16 references

Sorted by citations

Items 201–296 of 296

How Should We Use the Wearable Cardioverter-Defibrillator in Japan?
Shimizu, A. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-1188 · Cited by 3
Is the Wearable Cardioverter-Defibrillator the Answer for Early Post-Myocardial Infarction Patients at Risk for Sudden Death?
Zei, P. C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.022 · Cited by 3
Patient selection for wearable cardioverter defibrillator therapy after myocardial infarction: How can we incorporate compliance into decision‐making?
Younis, A., & Goldenberg, I. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14403 · Cited by 3
Clinical outcomes during and after wearable cardioverter defibrillator use in Japanese patients with heart failure: A single‐center experience
Kikuchi, N., Shiga, T., Sugawara, Y., Suzuki, A., Minami, Y., Hattori, H., Shoda, M., Hagiwara, N., & Yamaguchi, J. (2024) · Journal of Arrhythmia · doi:10.1002/joa3.13158 · Cited by 2
Wearable Cardioverter Defibrillator as a Treatment in Patients with Heart Failure of Various Aetiologies—A Series of Ten Cases Within the BIA-VEST Registry
Kazberuk, M., Pogorzelski, P., Kuźma, Ł., Kurasz, A., Róg‐Makal, M., Matys, U., Tokarewicz, J., Kralisz, P., & Dobrzycki, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13247686 · Cited by 2
Technological advances within digital medicine
Altibi, A. M. A., Alaref, S. J., & Khosravi, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820273-9.00001-4 · Cited by 2
The Subcutaneous Implantable Cardioverter Defibrillator
Mangels, D. R., & Frishman, W. H. (2016) · Cardiology in Review · doi:10.1097/crd.0000000000000099 · Cited by 2
Highlights of the Year in JACC 2010
DeMaria, A. N., Bax, J. J., Ben‐Yehuda, O., Feld, G. K., Greenberg, B., Hall, J. L., Hlatky, M. A., Lew, W. Y. W., Lima, J. A. C., Maisel, A. S., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.12.007 · Cited by 2
Quinine Syncope Diagnosed by Life Vest
Keriakos, R. A. N. (2015) · Clinical and Experimental Pharmacology · doi:10.4172/2161-1459.1000172 · Cited by 2
Surgical and electrophysiological considerations in the management of a patient with a subcutaneous implantable cardioverter-defibrillator undergoing coronary artery bypass surgery
Angel, B., Overcash, J., Fischer, W., & Fontaine, J. M. (2016) · HeartRhythm Case Reports · doi:10.1016/j.hrcr.2016.09.002 · Cited by 2
Misunderstood or Mistrusted? The Under-Utilization of the Wearable Cardioverter Defibrillator in Clinical Practice
Jagadish, P. S., Aziz, M., Chinta, V., & Khouzam, R. N. (2018) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2018.09.002 · Cited by 2
Recent Updates in the Role of Wearable Cardioverter Defibrillator for Prevention of Sudden Cardiac Death
Kirolos, I., Jones, D. W., Hesterberg, K. G., Yarn, C., Khouzam, R. N., & Levine, Y. C. (2019) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-019-0746-z · Cited by 2
Health Technology Assessment on the use of the Wearable Cardioverter Defibrillator in Patients with Myocardial Infarction and with ICD Explant
Cortesi, P. A., Botto, G. L., D’Angiolella, L. S., Scalone, L., Ponti, R. D., Boriani, G., & Mantovani, L. G. (2021) · Farmeconomia Health economics and therapeutic pathways · doi:10.7175/fe.v22i1s.1486 · Cited by 2
Novelties in the treatment of heart failure
Souček, F., & Novák, J. (2017) · Vnitřní lékařství · doi:10.36290/vnl.2017.053 · Cited by 2
Successful Management of a Young Athlete with Type 2 Long QT Syndrome by Genotype-specific Risk Stratification and Bridging Therapy with a Wearable Cardioverter Defibrillator
Kojima, K., Kato, K., Fujii, Y., Okuyama, Y., Ohno, S., Ozawa, T., Horie, M., & Nakagawa, Y. (2022) · Internal Medicine · doi:10.2169/internalmedicine.8093-21 · Cited by 2
Sudden Cardiac Death
Magnusson, P. O., & LeQuang, J. A. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.89286 · Cited by 2
Risk Factors for Arrhythmic Death, Overall Mortality, and Ventricular Tachyarrhythmias Requiring Shock After Myocardial Infarction
Lai, M., Cheung, C. C., Olgin, J. E., Pletcher, M. J., Vittinghoff, E., Lin, F., Hue, T. F., & Lee, B. K. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.10.009 · Cited by 2
A novel artificial intelligence based algorithm to reduce wearable cardioverter-defibrillator alarms
Arkles, J., Delaughter, C., & D'Souza, B. A. (2023) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-023-01497-w · Cited by 2
Der tragbare Kardioverter-Defibrillator
Helms, T. M., Muller, A. M., Schwab, J. O., Bänsch, D., Karle, C. A., Klingenheben, T., Zugck, C., & Perings, C. A. (2015) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-015-0365-7 · Cited by 2
Gimmick or Godsend? The Wearable Cardioverter Defibrillator (WCD)
Simpson, C. S. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.02.034 · Cited by 2
Technological advances in cardiac pacing and defibrillation
Bun, S., Squara, F., Scarlatti, D., Théodore, G., Lațcu, D. G., Hasni, K., Benaïch, F. A., Allouche, E., Saoudi, N. C., & Ferrari, É. (2019) · Heart Vessels and Transplantation · doi:10.24969/hvt.2019.129 · Cited by 1
Cost-utility analysis of the wearable cardioverter defibrillator in high-risk post-myocardial infarction patients in the Spanish healthcare system
Costello, J. G., García, V. E., Moloney, E., Kontogiannis, V., Javanbakht, M., Goromonzi, F., Both, B., & Moreno, R. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1832880 · Cited by 1
Schrittmacherabhängigkeit und/oder rezidivierende ICD-Therapien
Möller, V., Hölschermann, F., Schau, T., & Butter, C. (2013) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-013-0281-7 · Cited by 1
Application of ICD guidelines and indications in a community-based academic hospital: a case series-based discussion
Fan, W., & Khalighi, K. (2014) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.3402/jchimp.v4.23909 · Cited by 1
Indications for a Wearable Cardioverter-Defibrillator
Dewland, T. A., Olgin, J. E., & Lee, B. K. (2011) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2011.05.001 · Cited by 1
Cardioverter defibrillator therapy in the primary and secondary prevention of sudden cardiac death
Becker, R., Zitron, E., Thomas, D., & Katus, H. A. (2012) · Cited by 1
Where has VFib gone? Why today's EMS crews see less ventricular fibrillation in the field.
Salvucci, A. (2010) · PubMed · doi:10.1016/s0197-2510(10)70300-4 · Cited by 1
Die Defibrillatorweste
Duncker, D., Bauersachs, J. K., & Veltmann, C. (2016) · Der Internist · doi:10.1007/s00108-016-0110-2 · Cited by 1
Optimal Strategies for Mitigating Sudden Cardiac Death Risk in At-risk Patients with Structural Heart Disease
Boey, E., & Kojodjojo, P. (2018) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2018.090204 · Cited by 1
Efficacy of Wearable Cardioverter Defibrillators in 2 Children After Cardiopulmonary Arrest
Imamura, T., Sumitomo, N., Muraji, S., Osada, Y., Oyanagi, T., Kojima, T., Yoshiba, S., & Kobayashi, T. (2019) · Japanese Journal of Electrocardiology · doi:10.5105/jse.39.115 · Cited by 1
A missed opportunity for timely intervention to prevent a life-threatening event
Khan, M., Nangia, V., Bhatia, A., Mortada, M. E., Niazi, I. K., & Jahangir, A. (2022) · HeartRhythm Case Reports · doi:10.1016/j.hrcr.2022.01.011 · Cited by 1
Bridging Implantable Cardioverter-Defibrillator Patients Undergoing Radiotherapy with a Wearable Cardioverter-Defibrillator
(2023) · Cardiology Open Access · doi:10.33140/coa.08.01.04 · Cited by 1
EFFECTIVENESS OF WEARABLE DEFIBRILLATORS: SYSTEMATIC REVIEW AND QUALITY OF EVIDENCE
Uyei, J., & Braithwaite, R. S. (2014) · International Journal of Technology Assessment in Health Care · doi:10.1017/s026646231400004x · Cited by 1
ESC-Leitlinien 2015 zu ventrikulären Arrhythmien und zur Prävention des plötzlichen Herztodes
Fink, T., Kück, K., & Metzner, A. (2015) · Herz · doi:10.1007/s00059-015-4380-6 · Cited by 1
Wearable Cardioverter Defibrillators
Ferrick, A. M., Tian, D., Vudathaneni, V. K. P., Shevchuk, O. L., Ferrick, N. J., & Frishman, W. H. (2016) · Cardiology in Review · doi:10.1097/crd.0000000000000120 · Cited by 1
The wearable defibrillator
Reek, S. (2016) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000345 · Cited by 1
Value of The Wearable Cardioverter Defibrillator (WCD) as a Bridging-Therapy before Implantation of a Cardioverter Defibrillator (ICD).
Doz., P., & Sperzel, J. (2016) · PubMed Central · doi:10.4022/jafib.1247 · Cited by 1
The Wearable Cardioverter Defibrillator: A Case Study Illustrating Physical Therapy Implications and Management in the Inpatient Setting
Perillo, L., & Sweeney, G. (2018) · Physical Therapy · doi:10.1093/ptj/pzy106 · Cited by 1
Defibrillatorweste
Duncker, D., & Veltmann, C. (2018) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-018-0601-z · Cited by 1
The Wearable Cardioverter-Defibrillator
Magnusson, P. O., Pergolizzi, J. V., & LeQuang, J. A. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.90663 · Cited by 1
The wearable cardioverter-defibrillator is needed for most high-risk patients
Lee, B. K. (2020) · Heart Rhythm O2 · doi:10.1016/j.hroo.2020.07.001 · Cited by 1
Reassessment of practical usage and accumulation of real‐world data of wearable cardioverter defibrillator (WCD) in Japan—Design paper for J‐WCDR study
Niwano, S., Abe, H., Takagi, M., Sekiguchi, Y., Iwasaki, Y., Kato, R., Kondo, Y., Kurita, T., Nitta, T., Nogami, A., et al. (2020) · Journal of Arrhythmia · doi:10.1002/joa3.12456 · Cited by 1
Active Ventricular Arrhythmias
de Luna, A. B. (2012) · Wiley eBooks · doi:10.1002/9781118392041.ch16 · Cited by 1
Wearable cardioverter defibrillator
Sperzel, J. (2016) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-016-0429-3 · Cited by 1
Long-term use of the wearable cardioverter-defibrillator: prolonging life or prolonging indecision?
ADELSTEIN, E. C. (2016) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-016-0212-8 · Cited by 1
Mitigating Post-Extraction Risk
Chung, M. K. (2016) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2016.10.015 · Cited by 1
Self-citation
The Wearable Cardioverter-Defibrillation
ADELSTEIN, E. C., & Saba, S. (2017) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2017.10.011 · Cited by 1
Wearable cardioverter defibrillators: dead on arrival or chance of survival?
Jagadish, P. S., & Khouzam, R. N. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.07.04 · Cited by 1
Reply to: Comments on the authors’ reply to the critical appraisal concerning “Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study”
Ettinger, S., Stanak, M., Szymański, P., Wild, C., Haček, R. T., Erčević, D., Grenković, R., Goetz, G., & Huić, M. (2019) · Medical Devices Evidence and Research · doi:10.2147/mder.s202581 · Cited by 1
Arrhythmias in Different Heart Diseases and Situations
de Luna, A. B. (2011) · Wiley eBooks · doi:10.1002/9781444391749.ch11
Indications for Pacemakers, ICDs and CRT: Identifying Patients Who Benefit from Cardiac Rhythm Devices
Gami, A. S., Hayes, D. L., Asirvatham, S. J., & Friedman, P. A. (2012) · Wiley eBooks · doi:10.1002/9781118483923.ch3
65-jähriger Patient mit tragbarem Kardioverter/Defibrillator nach akutem Herzinfarkt
Horlbeck, F., Nickenig, G., & Schwab, J. O. (2015) · Der Internist · doi:10.1007/s00108-015-3782-0
An under-utilized opportunity: The wearable cardioverter-defibrillator (WCD)
Jain, A. (2013) · Medical Practice and Reviews · doi:10.5897/mpr12.017
Optimal Utilization and Management of Implanted Cardiac Rhythm Devices in Patients Hospitalized for Heart Failure
Randolph, T. C., & Piccini, J. P. (2013) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.04.006
Indications for a Wearable Cardioverter
Dewland, T. A., Olgin, J. E., & Lee, B. K. (2011)
Implantable Cardioverter and Defibrillator Therapy
Ahmad, A., Garlitski, A., Link, M. S., Homoud, M. K., & Estes, N. A. M. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4441-0_17
Wearable cardioverter–defibrillators in the spotlight
Mearns, B. M. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.132
The Latest Device for Prevention of Sudden Cardiac Death
Kohno, R., Oginosawa, Y., Hayashi, K., Ohe, H., Takahashi, M., & Abe, H. (2015) · Japanese Journal of Electrocardiology · doi:10.5105/jse.35.227
The wearable cardioverter defibrillator as a bridge to implantable defibrillator post myocardial infarction: what do we know?
Barsheshet, A., Vamvouris, T., & Goldenberg, I. (2016) · Expert Review of Medical Devices · doi:10.1080/17434440.2016.1200969
Optimización del tratamiento farmacológico en pacientes con disfunción sistólica severa del ventrículo izquierdo en una unidad de insuficiencia cardiaca: implicaciones en la indicación de un desfibrilador automático implantable en prevención primaria y factores predictores de ausencia de remodelado reverso del ventrículo izquierdo
Pérez‐Rodon, J. (2016) · TDX (Tesis Doctorals en Xarxa)
Management of Ventricular Tachyarrhythmia Early After Myocardial Infraction: The Role of Implantable Cardioverter Defibrillator and Ablation
Mikaeili, J. (2016) · doi:10.17795/cce-7627
„Mismanagement“ oder „misunderstanding“?
Klein, H. (2016) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-016-0470-2
Prevention of Sudden Cardiac Death
Hussein, A. A., & Chung, M. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42880-4.00022-4
Self-citation
A Wearable Cardioverter Defibrillator for Patients with Congenital Heart Disease: A Report of Two Cases
Nishimura, T., Toyohara, K., Inai, K., Shinohara, T., Park, I. S., & Shoda, M. (2017) · Japanese Society of Pediatric Cardiology and Cardiac Surgery · doi:10.9794/jspccs.33.228
Der tragbare Defibrillator (WCD) – EHRA-Review
Perings, C. A. (2017) · Aktuelle Kardiologie · doi:10.1055/s-0043-110674
Arrhythmias in Peripartum
Honigberg, M. C., & Givertz, M. M. (2015)
Early Repolarization Syndrome and Implantable Cardioverter–Defibrillators
Kurita, T. (2017) · Springer eBooks · doi:10.1007/978-981-10-3379-7_8
Implantable and Wearable Defibrillator Therapy
Saba, S., & Estes, N. A. M. (2017) · Cardiovascular medicine · doi:10.1007/978-3-319-58000-5_11
Patienten mit einer tragbaren Defibrillatorweste („wearable cardioverter-defibrillator“, WCD)
Schlitt, A., Guha, M., Noutsias, M., Klein, H. H., & Klein, H. H. (2017) · Herz · doi:10.1007/s00059-017-4650-6
Use of Wearable Cardioverter Defibrillator Shortens the ICU Stay and Enables Safe Management in a General Ward
Yoshihiro, S., Sasaki, S., Toyama, Y., Nishizaki, K., Kinjo, T., Ishida, Y., Endo, T., Nishizaki, F., Itoh, T., Yokota, T., et al. (2018) · Hirosaki igaku · doi:10.32216/hirosakiigaku.68.2-4_135
Topics about new cardiac implantable devices
Kitano, T., Okajima, M., & Taniguchi, T. (2019) · Journal of the Japanese Society of Intensive Care Medicine · doi:10.3918/jsicm.26_373
Wearable cardioverter defibrillator for foreigners, a Tajikistani woman with ventricular fibrillation: a case report
Ichimura, K., Nishihara, M., Mukai, Y., Uwatoku, T., Tokuda, K., Akahoshi, T., Tsutsui, H., & Taguchi, T. (2019) · Journal of the Japanese Society of Intensive Care Medicine · doi:10.3918/jsicm.26_385
Who Should Receive a Wearable Defibrillator Vest at Hospital Discharge?
Kachur, S. M., & Morin, D. P. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1215-8
Wearable Cardioverter-Defibrillators
ADELSTEIN, E. C., Wang, N. C., & Saba, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-22882-8_3
Defibrillation Therapy
Zaręba, W., Aktaş, M. K., & Lau, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-37804-8.00016-x
Analysis of Patients with LifeVest after Cardiac Surgery
Hajiyev, V., Erkenov, T., Smechowski, A., Just, S., Grimmig, O., & Fritzsche, D. (2020) · World Journal of Cardiovascular Surgery · doi:10.4236/wjcs.2020.105008
Use and outcomes of wearable cardioverter-defibrillators in a large integrated academic health system
Kahn, P. A., Gruen, J., Thomas, A., Ahmad, T., & Desai, N. R. (2020) · American Heart Journal · doi:10.1016/j.ahj.2020.04.007
The past, present, and future of implantable cardioverter-defibrillators
Jones, R. P., & Berger, R. D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813704-8.00030-9
Wenn die Weste einige Nummern zu groß ist: Sinn und Unsinn der LifeVest bei Postinfarktpatienten
Bonnemeier, H. (2020) · Aktuelle Kardiologie · doi:10.1055/a-1289-7137
The IC‐D score for predicting prophylactic cardioverter‐defibrillator implantation following acute myocardial infarction
Clémenty, N., Bensaid, R., Bouteau, J. M., Fedida, J., Kiavue, Y., Socié, P., Ackermann, R., Goralski, M., Fauchier, L., Bernard, A. B., et al. (2021) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14244
Indications for Pacemakers, Implantable Cardioverter‐Defibrillators, and Cardiac Resynchronization Therapy
Kancharla, K., Hayes, D. L., Asirvatham, S. J., & Friedman, P. A. (2021) · Wiley eBooks · doi:10.1002/9781119264002.ch3
Appendix
de Luna, A. B., & FCCS, A. B. M. F. F. (2017) · doi:10.1002/9781119212782.app1
Active Ventricular Arrhythmias
de Luna, A. B. (2011) · doi:10.1002/9781444391749.ch5
Arrhythmias in Different Heart Diseases and Situations
de Luna, A. B., & FCCS, A. B. M. F. F. (2017) · Wiley eBooks · doi:10.1002/9781119212782.ch11
Wearable Treatment Device: Wearable Cardioverter Defibrillator (WCD)
亘, 松. (2017) · JAPANES JOURNAL OF MEDICAL INSTRUMENTATION · doi:10.4286/jjmi.87.27
Appendix
de Luna, A. B. (2011) · doi:10.1002/9781444391749.app1
Handling SCD risk in adult congenital heart disease: Should we InVEST in the WCD?
Narayanan, K. (2022) · Indian Pacing and Electrophysiology Journal · doi:10.1016/j.ipej.2022.08.004
The wearable cardioverter-defibrillator in 2023: current evidence and clinical indications
Erath, J. W., & Wakili, R. (2023) · Cardiologia Hungarica · doi:10.26430/chungarica.2023.53.3.198
Advancements in automated external and wearable cardiac defibrillators
Aldaas, O. M., & Birgersdotter-Green, U. M. (2024) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000001189
Cardiovascular Implantable Electronic Devices and Dialysis Access
Saad, T. F., & Koplan, B. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-70514-4_52
Patient Perspectives on the Current Paradigm of Non-Invasive Cardiac Testing Through an Emergency Department Observation Unit: A Survey Study
Reynolds, J. C., Oostema, J. A., Sierzant, C., & Sherwin, K. (2025) · Cureus · doi:10.7759/cureus.85296
Should LifeVest Be Worn During Shower: A Case Report
Lam, V. S., Huynh, K. H., & Tran, P. (2025) · Cureus · doi:10.7759/cureus.88663
Variability in Prescribing Patterns of Wearable Cardiac Defibrillators: Current Data, Guidelines, Challenges, and Controversies
Guglieri, M., Lenormand, T., Bodin, A., Bisson, A., & Fauchier, L. (2025) · Current Cardiology Reports · doi:10.1007/s11886-025-02321-9
The ‘CIED Team’ Approach to Device-Related Complications
Mazzotta, R., Cosco, L., Fedeli, F., Ricciardi, G., Bambagioni, G., Bernini, M., Scanferla, R., Pieragnoli, P., Perrotta, L., & Checchi, L. (2026) · JACC Case Reports · doi:10.1016/j.jaccas.2026.108976
Wearable Cardioverter-Defibrillator in Patients at Transient Risk of Sudden Cardiac Death: State of the Art and Contemporary Clinical Evidence
Matteucci, A., Bonanni, M., Mariani, M. V., Sgarra, L., Nesti, L., Pierucci, N., Fusco, S. A. D., Fedele, S., Nardi, F., & Colivicchi, F. (2026) · Diagnostics · doi:10.3390/diagnostics16182990
Wearing Protection or Wearing Assumptions? A Critical Reappraisal of the Wearable Cardioverter-Defibrillator
Sensi, F. D., Baratta, P., & Limbruno, U. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15218358

Authors: Chung, M. K., Szymkiewicz, S. J., Shao, M., Zishiri, E., Niebauer, M. J., Lindsay, B. D., & Tchou, P. J.
Affiliations: Cleveland Clinic (US)
ZOLL Medical Corporation (United States) (US)
Corresponding author: Chung, Mina K.
ORCID: Chung, Mina K.
Szymkiewicz, Steven J.
Shao, Mingyuan
Zishiri, Edwin
Niebauer, Mark J.
Tchou, Patrick J.
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 2010-07
Volume: 56
Issue: 3
Pages: 194-203
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/j.jacc.2010.04.016
PMC: PMC2962668
OpenAlex: W2159588890
Cited by: 297
References: 16
Citations by year: 2026: 5 · 2025: 6 · 2024: 9 · 2023: 15 · 2022: 11 · 2021: 19 · 2020: 26 · 2019: 21 · 2018: 28 · 2017: 33 · 2016: 39 · 2015: 20 · 2014: 14 · 2013: 19 · 2012: 13
FWCI: 10.98
Type: journal article
Language: en
Update notices: erratum (2011-01-11)
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 1111 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Medtronic, Inc.
Boston Scientific
St. Jude Medical
Biotronik
Medtronic
National Institutes of Health (NIH R01 HL090620)
ZOLL
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Health Sciences › Medicine › Emergency Medicine › Cardiac Arrest and Resuscitation
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords: wearable cardioverter defibrillator, medication adherence, sudden cardiac death prevention, ventricular tachycardia, ventricular fibrillation, implantable cardioverter-defibrillator, survival, asystole, sudden cardiac arrest, post-market registry
MeSH terms: Female, Humans, Male, Middle Aged, Patient Compliance, Ventricular Fibrillation, Death, Sudden, Cardiac, Tachycardia, Ventricular, Defibrillators

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Aggregate National Experience With the Wearable Cardioverter-Defibrillator

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks